Editors' Note regarding “Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists”

Receptor Regulation ◽

Type I ◽

Editor's Note Regarding “Mechanism of Corticotropin-Releasing Factor Type I Receptor Regulation by Nonpeptide Antagonists”

Molecular Pharmacology ◽

10.1124/mol.68.1.260 ◽

2005 ◽

Vol 68 (1) ◽

pp. 260-260 ◽

Cited By ~ 1

Keyword(s):

Receptor Regulation ◽

Type I ◽

Ligand Affinity for Amino-Terminal and Juxtamembrane Domains of the Corticotropin Releasing Factor Type I Receptor: Regulation by G-Protein and Nonpeptide Antagonists

Biochemistry ◽

10.1021/bi036110a ◽

2004 ◽

Vol 43 (13) ◽

pp. 3996-4011 ◽

Cited By ~ 57

Author(s):

Sam R. J. Hoare ◽

Sue K. Sullivan ◽

David A. Schwarz ◽

Nicholas Ling ◽

Wylie W. Vale ◽

...

Keyword(s):

G Protein ◽

Receptor Regulation ◽

Type I ◽

Ligand Affinity ◽

Amino Terminal ◽

Mechanism of Corticotropin-Releasing Factor Type I Receptor Regulation by Nonpeptide Antagonists

Molecular Pharmacology ◽

10.1124/mol.63.3.751 ◽

2003 ◽

Vol 63 (3) ◽

pp. 751-765 ◽

Cited By ~ 53

Author(s):

Sam R. J. Hoare ◽

Sue K. Sullivan ◽

Nicholas Ling ◽

Paul D. Crowe ◽

Dimitri E. Grigoriadis

Keyword(s):

Receptor Regulation ◽

Type I ◽

Brain Penetrance, Receptor Occupancy and Antistress In Vivo Efficacy of a Small Molecule Corticotropin Releasing Factor Type I Receptor Selective Antagonist

Neuropsychopharmacology ◽

10.1016/s0893-133x(02)00299-3 ◽

2002 ◽

Vol 27 (2) ◽

pp. 194-202 ◽

Cited By ~ 119

Author(s):

S Heinrichs

Keyword(s):

Small Molecule ◽

Receptor Occupancy ◽

Type I ◽

In Vivo Efficacy ◽

Selective Antagonist ◽

Isolation and Pharmacological Characterization of Two Functional Splice Variants of Corticotropin‐Releasing Factor Type 2 Receptor from Tupaia belangeri

Journal of Neuroendocrinology ◽

10.1046/j.1365-2826.1999.00348.x ◽

1999 ◽

Vol 11 (6) ◽

pp. 419-428 ◽

Cited By ~ 51

Author(s):

Palchaudhuri ◽

Hauger ◽

Wille ◽

Fuchs ◽

Dautzenberg§

Keyword(s):

Splice Variants ◽

Pharmacological Characterization ◽

Tupaia Belangeri ◽

Angiotensin II upregulates transforming growth factor- type I receptor on rat vascular smooth muscle cells

American Journal of Hypertension ◽

10.1016/s0895-7061(99)00152-1 ◽

2000 ◽

Vol 13 (2) ◽

pp. 191-198 ◽

Cited By ~ 38

Author(s):

N. Fukuda ◽

W.-Y. Hu ◽

A. Kubo ◽

H. Kishioka ◽

C. Satoh ◽

...

Keyword(s):

Smooth Muscle ◽

Angiotensin Ii ◽

Growth Factor ◽

Vascular Smooth Muscle ◽

Smooth Muscle Cells ◽

Vascular Smooth Muscle Cells ◽

Transforming Growth Factor ◽

Muscle Cells ◽

Type I ◽

Enduring, Handling-Evoked Enhancement of Hippocampal Memory Function and Glucocorticoid Receptor Expression Involves Activation of the Corticotropin-Releasing Factor Type 1 Receptor

Endocrinology ◽

10.1210/en.2004-1285 ◽

2005 ◽

Vol 146 (9) ◽

pp. 4090-4096 ◽

Cited By ~ 76

Author(s):

Kristina A. Fenoglio ◽

Kristen L. Brunson ◽

Sarit Avishai-Eliner ◽

Blake A. Stone ◽

Bhumika J. Kapadia ◽

...

Keyword(s):

Glucocorticoid Receptor ◽

Memory Function ◽

Receptor Expression ◽

Effect of pituitary growth hormone and insulin-like growth factor type-I on proliferation, apoptosis and hormone secretion of the placental cell line JEG-3

Gynecological Endocrinology ◽

10.3109/09513591003592726 ◽

2010 ◽

Vol 26 (4) ◽

pp. 302-306 ◽

Cited By ~ 3

Author(s):

Agnieszka Rak-Mardyła ◽

Ewa Łucja Gregoraszczuk

Keyword(s):

Growth Hormone ◽

Growth Factor ◽

Cell Line ◽

Hormone Secretion ◽

Type I ◽

Insulin Like Growth Factor ◽

Placental Cell ◽

Pituitary Growth Hormone ◽

Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: Implications for vascular disease in hyperinsulinemic states

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.89.3.1148-c ◽

1992 ◽

Vol 89 (3) ◽

pp. 1148-1148

Keyword(s):

Growth Factor ◽

Vascular Disease ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Type I ◽

Factor Type ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/j.bmcl.2015.10.010 ◽

2015 ◽

Vol 25 (22) ◽

pp. 5111-5114 ◽

Cited By ~ 3

Author(s):

Jeffrey S. Stehouwer ◽

Chase H. Bourke ◽

Michael J. Owens ◽

Ronald J. Voll ◽

Clinton D. Kilts ◽

...

Keyword(s):

Binding Affinity ◽